Expands the exemption for receipts from the sale of prescription drugs from commercial activity subject to the corporate activity tax to include critical access pharmacies. Applies to tax years beginning on or after January 1, 2026. Takes effect on the 91st day following adjournment sine die.
No hearings or votes scheduled.